The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development.
Open accessAbstract
CD44 is implicated in the regulation of tumor growth and metastasis but the mechanism by which expression of different CD44 isoforms determines the rate of primary and secondary tumor growth remains unclear. In the present study we use a human melanoma transfected with wild-type and mutant forms of CD44 to determine which functional property of the CD44 molecule is critical in influencing tumor behavior. We show that expression of a wild-type CD44 isoform that binds hyaluronic acid augments the rapidity of tumor formation by melanoma cells in vivo, whereas expression of a CD44 mutant, which does not mediate cell attachment to hyaluronate, fails to do so. The importance of CD44-hyaluronate interaction in tumor development is underscored by the differential inhibitory effect of soluble wild-type and mutant CD44-Ig fusion proteins on melanoma growth in vivo. Whereas local administration of a mutant, nonhyaluronate binding, CD44-Ig fusion protein has no effect on subcutaneous melanoma growth in mice, infusion of wild-type CD44-Ig is shown to block tumor development. Taken together, these observations suggest that the tumor growth promoting property of CD44 is largely dependent on its ability to mediate cell attachment to hyaluronate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD44 is the principal cell surface receptor for hyaluronate
Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C. B., & Seed, B. (1990) · Cell · doi:10.1016/0092-8674(90)90694-a · Cited by 2,438
Self-citationA new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Hauβmann, I., Matzku, S., Wenzel, A., Ponta, H., & Herrlich, P. (1991) · Cell · doi:10.1016/0092-8674(91)90403-l · Cited by 1,654
Proteoglycans as modulators of growth factor activities
Ruoslahti, E., & Yamaguchi, Y. (1991) · Cell · doi:10.1016/0092-8674(91)90308-l · Cited by 1,343
Screaton, G. R., Bell, M. V., Jackson, D. G., Cornelis, F. B., Gerth, U., & Bell, J. I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12160 · Cited by 1,015
Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system.
Aruffo, A., & Seed, B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8573 · Cited by 784
Self-citationStamenkovic, I., Amiot, M., Pesando, J. M., & Seed, B. (1989) · Cell · doi:10.1016/0092-8674(89)90638-7 · Cited by 672
Self-citationMiyake, K., Underhill, C. B., Lesley, J., & Kincade, P. W. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.1.69 · Cited by 618
Stamenkovic, I., Aruffo, A. A., Amiot, M., & Seed, B. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07955.x · Cited by 573
Self-citationGoldstein, L. A., Zhou, D. F. H., Picker, L. J., Minty, C. N., Bargatze, R. F., Ding, J. F., & Butcher, E. C. (1989) · Cell · doi:10.1016/0092-8674(89)90639-9 · Cited by 555
Laurent, T. C., & Fraser, J. R. E. (1992) · PubMed · Cited by 550
Cited by
Hyaluronan: from extracellular glue to pericellular cue
Toole, B. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1391 · Cited by 2,125
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754
Self-citationCD44: Structure, Function and Association with the Malignant Process
(1997) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60101-3 · Cited by 1,016
McKee, C. M., Penno, M. B., Cowman, M., Burdick, M. D., Strieter, R. M., Bao, C., & Noble, P. W. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119054 · Cited by 806
Yu, Q., & Stamenkovic, I. (1999) · Genes & Development · doi:10.1101/gad.13.1.35 · Cited by 713
Self-citationGoodison, S., Urquidi, V, & Tarin, D. (1999) · Molecular Pathology · doi:10.1136/mp.52.4.189 · Cited by 679
Resolution of Lung Inflammation by CD44
Teder, P., Vandivier, R. W., Jiang, D., Liang, J., Cohn, L., Puré, E., Henson, P. M., & Noble, P. W. (2002) · Science · doi:10.1126/science.1069659 · Cited by 677
Yan, Y., Zuo, X., & Wei, D. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0048 · Cited by 633
Toole, B. P. (2001) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2000.0244 · Cited by 570
Naor, D., Nedvetzki, S., Golan, I., Melnik, L., & Faitelson, Y. (2002) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360290795574 · Cited by 557
Morrison, H., Sherman, L. S., Legg, J., Banine, F., Isacke, C., Haipek, C. A., Gutmann, D. H., Ponta, H., & Herrlich, P. (2001) · Genes & Development · doi:10.1101/gad.189601 · Cited by 536
Auvinen, P., Tammi, R., Parkkinen, J., Tammi, M., Ågren, U., Johansson, R., Hirvikoski, P., Eskelinen, M., & Kosma, V.-M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64757-8 · Cited by 493
Platt, V. M., & Szoka, F. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800024g · Cited by 456
Expression of CD44 in Apc and TcfMutant Mice Implies Regulation by the WNT Pathway
Wielenga, V. J. M., Smits, R., Korinek, V., Smit, L., Kielman, M., Fodde, R., Clevers, H., & Pals, S. T. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65297-2 · Cited by 433
Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression
Sherman, L., Sleeman, J., Herrlich, P., & Ponta, H. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90100-7 · Cited by 432
Hyaluronic acid: the scientific and clinical evidence
Price, R. D., Berry, M. G., & Navsaria, H. A. (2007) · Journal of Plastic, Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2007.03.005 · Cited by 413
The interaction of versican with its binding partners
WU, Y. J., PIERRE, D. P. L., WU, J., YEE, A. J., & YANG, B. B. (2005) · Cell Research · doi:10.1038/sj.cr.7290318 · Cited by 400
Liposomal paclitaxel formulations
Koudelka, Š., & Turánek, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.09.006 · Cited by 366
Ghatak, S., Misra, S., & Toole, B. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202404200 · Cited by 332
The normal structure and function of CD44 and its role in neoplasia
Sneath, R. J., & Mangham, D. C. (1998) · Molecular Pathology · doi:10.1136/mp.51.4.191 · Cited by 332
A druggable copper-signalling pathway that drives inflammation
Solier, S., Müller, S., Cañeque, T., Versini, A., Mansart, A., Sindikubwabo, F., Baron, L., Emam, L., Gestraud, P., Pantoș, G. D., et al. (2023) · Nature · doi:10.1038/s41586-023-06017-4 · Cited by 330
Mohamadzadeh, M., DeGrendele, H., Arizpe, H., Estess, P., & Siegelman, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1604 · Cited by 313
Involvement of CD44, a molecule with a thousand faces, in cancer dissemination
Naor, D., Wallach-Dayan, S. B., Zahalka, M. A., & Sionov, R. V. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.015 · Cited by 309
Biocompatibility and biodegradability of metal organic frameworks for biomedical applications
Singh, N., Qutub, S., & Khashab, N. M. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb01044a · Cited by 303
Hall, C. L., Yang, B., Yang, X., Zhang, S., Turley, M., Samuel, S., Lange, L. A., Wang, C., Curpen, G. D., Savani, R. C., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90048-9 · Cited by 293
CD44 regulates epigenetic plasticity by mediating iron endocytosis
Müller, S., Sindikubwabo, F., Cañeque, T., Lafon, A., Versini, A., Lombard, B., Loew, D., Wu, T.-D., Ginestier, C., Charafe-Jauffret, E., et al. (2020) · Nature Chemistry · doi:10.1038/s41557-020-0513-5 · Cited by 288
Anti-CD44 treatment abrogates tissue aedema and leukocyte infiltration in murine arthrtis
Mikecz, K., Brennan, F. R., Kim, J. H., & Glant, T. T. (1995) · Nature Medicine · doi:10.1038/nm0695-558 · Cited by 277
Zohar, R., Suzuki, N., Suzuki, K., Arora, P., Glogauer, M., McCulloch, C. A. G., & Sodek, J. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200007)184:1<118::aid-jcp13>3.0.co;2-y · Cited by 276
Kaya, G., Rodriguez, I., Jorcano, J. L., Vassalli, P., & Stamenkovic, I. (1997) · Genes & Development · doi:10.1101/gad.11.8.996 · Cited by 274
Self-citationHyaluronic acid and albumin based nanoparticles for drug delivery
Lei, C., Liu, X.-R., Chen, Q.-B., Li, Y., Zhou, J.-L., Zhou, L.-Y., & Zou, T. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.01.033 · Cited by 266
Dohadwala, M., Batra, R. K., Luo, J., Lin, Y., Krysan, K., Põld, M., Sharma, S., & Dubinett, S. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m210707200 · Cited by 260
Okamoto, I., Kawano, Y., Tsuiki, H., Sasaki, J.-I., Nakao, M., Matsumoto, M., Suga, M., Ando, M., Nakajima, M., & Saya, H. (1999) · Oncogene · doi:10.1038/sj.onc.1202447 · Cited by 257
Glycosylation of CD44 negatively regulates its recognition of hyaluronan.
Katoh, S., Zheng, Z., Oritani, K., Shimozato, T., & Kincade, P. W. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.419 · Cited by 254
Mimeault, M., & Batra, S. K. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00885.x · Cited by 38
Metadata
- Authors
- Bartolazzi, A., Peach, R., Aruffo, A., & Stamenkovic, I.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1994-07-01
- Volume
- 180
- Issue
- 1
- Pages
- 53-66
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2143762419
- Cited by
- 331
- References
- 38
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.